| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Alzheimer’s Disease Research Center (Drs. Lopez, Becker, Klunk, Saxton, Hamilton, Kaufer, Sweet, Wisniewski, Kamboh, and DeKosky) and the Departments of Psychiatry (Drs. Lopez, Becker, Klunk, Saxton, Kaufer, Sweet, and DeKosky), Neurology (Drs. Lopez, Becker, Kaufer, and DeKosky), Pathology (Neuropathology) (Dr. Hamilton), Radiology (Dr. Meltzer), Epidemiology (Dr. Wisniewski), and Genetics (Dr. Kamboh), University of Pittsburgh School of Medicine, PA.
Address correspondence and reprint requests to Dr. Oscar L. Lopez, Neuropsychology Research Program, Oxford Building, 3501 Forbes Avenue, Suite 830, Pittsburgh, PA 15213.
OBJECTIVE: To describe the experience of a research clinic diagnosing AD during the last two decades, with special emphasis on patients who meet the National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association criteria for probable AD, their patterns of clinical presentation, and neuropathologic outcomes.
BACKGROUND: Probable AD has a heterogeneous clinical presentation, and can occur in the context of complicating factors. There are few reports, and none with this large of a sample, about the pattern of presentation, the nature of comorbidities, and the sensitivity and specificity of diagnosis.
RESULTS: The AD Research Center of Pittsburgh examined 1139 patients with probable AD between April 1983 and February 2000. Of these 1139 probable AD patients, 29 (2.5%) had slow progression, 27 (2%) had rapid progression, 70 (6%) had an atypical presentation, and 85 (7%) had coexistent cerebrovascular disease. Confluent periventricular white matter lesions were found in 348 (30.5%) patients with probable AD. The overall sensitivity for the diagnosis of AD was 97% and the specificity 80%. However, the accuracy for the diagnosis of AD varied over the years: from 1983 to 1989, the sensitivity was 94% and specificity 52%, and from 1990 to 2000, the sensitivity was 98% and specificity 88%.
CONCLUSION: Although the diagnosis of probable AD has been used to indicate the presence of a homogeneous clinical entity, these patients can vary in presentation, onset, or clinical course. This finding is of particular importance for the understanding of the pathophysiologic basis of the disease, and for the better identification of responders to dementia treatments. Although the sensitivity for the diagnosis of AD remained above 90% over the last two decades, the specificity increased, reflecting progressive improvement in the diagnosis of other dementing disorders.
This article has been cited by other articles:
|
|
 |
|
  O L Lopez, J T Becker, A S Wahed, J Saxton, R A Sweet, D A Wolk, W Klunk, and S T DeKosky Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease J. Neurol. Neurosurg. Psychiatry, June 1, 2009; 80(6): 600 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Wiley, B. J. Lopresti, S. Venneti, J. Price, W. E. Klunk, S. T. DeKosky, and C. A. Mathis Carbon 11-Labeled Pittsburgh Compound B and Carbon 11-Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease Arch Neurol, January 1, 2009; 66(1): 60 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Duara, D. A. Loewenstein, E. Potter, J. Appel, M. T. Greig, R. Urs, Q. Shen, A. Raj, B. Small, W. Barker, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease Neurology, December 9, 2008; 71(24): 1986 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Aizenstein, R. D. Nebes, J. A. Saxton, J. C. Price, C. A. Mathis, N. D. Tsopelas, S. K. Ziolko, J. A. James, B. E. Snitz, P. R. Houck, et al. Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly Arch Neurol, November 1, 2008; 65(11): 1509 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain, June 1, 2008; 131(6): 1630 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Larner Integrated care pathways in dementia: a challenge to National Institute for Health and Clinical Excellence/Social Care Institute for Excellence guidance Intl J Care Pathw, December 1, 2007; 11(3): 95 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Klunk, J. C. Price, C. A. Mathis, N. D. Tsopelas, B. J. Lopresti, S. K. Ziolko, W. Bi, J. A. Hoge, A. D. Cohen, M. D. Ikonomovic, et al. Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees J. Neurosci., June 6, 2007; 27(23): 6174 - 6184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Lingler, M. C. Nightingale, J. A. Erlen, A. L. Kane, C. F. Reynolds III, R. Schulz, and S. T. DeKosky Making Sense of Mild Cognitive Impairment: A Qualitative Exploration of the Patient's Experience Gerontologist, December 1, 2006; 46(6): 791 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Lopez, J. T. Becker, R. A. Sweet, F. J. Martin-Sanchez, and R. L. Hamilton Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology, August 22, 2006; 67(4): 660 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Klunk, B. J. Lopresti, M. D. Ikonomovic, I. M. Lefterov, R. P. Koldamova, E. E. Abrahamson, M. L. Debnath, D. P. Holt, G.-f. Huang, L. Shao, et al. Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-{beta} in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain J. Neurosci., November 16, 2005; 25(46): 10598 - 10606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Paraskevas, E. Kapaki, I. Liappas, I. Theotoka, I. Mamali, C. Zournas, and L. Lykouras The Diagnostic Value of Cerebrospinal Fluid Tau Protein in Dementing and Nondementing Neuropsychiatric Disorders J Geriatr Psychiatry Neurol, September 1, 2005; 18(3): 163 - 173. [Abstract] [PDF]
|
|
|
|
|
|
S. Bell-McGinty, O. L. Lopez, C. C. Meltzer, J. M. Scanlon, E. M. Whyte, S. T. DeKosky, and J. T. Becker Differential Cortical Atrophy in Subgroups of Mild Cognitive Impairment Arch Neurol, September 1, 2005; 62(9): 1393 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Lopez, L. H. Kuller, J. T. Becker, W. J. Jagust, S. T. DeKosky, A. Fitzpatrick, J. Breitner, C. Lyketsos, C. Kawas, and M. Carlson Classification of vascular dementia in the Cardiovascular Health Study Cognition Study Neurology, May 10, 2005; 64(9): 1539 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ganguli, H. H. Dodge, C. Shen, and S. T. DeKosky Mild cognitive impairment, amnestic type: An epidemiologic study Neurology, July 13, 2004; 63(1): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G B Frisoni, P h Scheltens, S Galluzzi, F M Nobili, N C Fox, P H Robert, H Soininen, L-O Wahlund, G Waldemar, and E Salmon Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1371 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Villareal, E. Grant, J. P. Miller, M. Storandt, D. W. McKeel, and J. C. Morris Clinical outcomes of possible versus probable Alzheimer's disease Neurology, September 9, 2003; 61(5): 661 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. L. Lopez, J. T. Becker, R. A. Sweet, W. Klunk, D. I. Kaufer, J. Saxton, M. Habeych, and S. T. DeKosky Psychiatric Symptoms Vary With the Severity of Dementia in Probable Alzheimer's Disease J Neuropsychiatry Clin Neurosci, August 1, 2003; 15(3): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Lopez, J. T. Becker, R. A. Sweet, W. Klunk, D. I. Kaufer, J. Saxton, and S. T. DeKosky Patterns of Change in the Treatment of Psychiatric Symptoms in Patients With Probable Alzheimer's Disease From 1983 to 2000 J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bell-McGinty, M. A. Butters, C. C. Meltzer, P. J. Greer, C. F. Reynolds III, and J. T. Becker Brain Morphometric Abnormalities in Geriatric Depression: Long-Term Neurobiological Effects of Illness Duration Am J Psychiatry, August 1, 2002; 159(8): 1424 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O L Lopez, J T Becker, S Wisniewski, J Saxton, D I Kaufer, and S T DeKosky Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 310 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Lopez, J. T. Becker, D. I. Kaufer, R. L. Hamilton, R. A. Sweet, W. Klunk, and S. T. DeKosky Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies Arch Neurol, January 1, 2002; 59(1): 43 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Sukonick, B. G. Pollock, R. A. Sweet, B. H. Mulsant, J. Rosen, W. E. Klunk, K. B. Kastango, S. T. DeKosky, and R. E. Ferrell The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease Arch Neurol, September 1, 2001; 58(9): 1425 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G B FRISONI Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 711 - 718. [Full Text] [PDF]
|
|
|
|
|
|
O.L. Lopez, J.T. Becker, W. Klunk, J. Saxton, R.L. Hamilton, D.I. Kaufer, R.A. Sweet, C. Cidis Meltzer, S. Wisniewski, M.I. Kamboh, et al. Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II Neurology, December 26, 2000; 55(12): 1863 - 1869. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
